DelveInsight’s, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ ...

Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...

AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory ...

During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

The Oxford, England-based biotechnology company develops medical tests. It described its EpiSwitch biomarkers as "an effective liquid biopsy method" meaning they can analyse blood samples. EpiSwitch ...

The broadcaster, 67, announced his diagnosis with stage four prostate cancer in June, saying he was ‘responding positively’ to treatment.

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Bill Bentley, Professor Know-it All, Passed Away, June 6, 2025, at the age of 80 after a battle with bladder cancer.

The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

Frequent cystoscopy for monitoring nonmuscle-invasive bladder cancer (NMIBC) is burdensome and costly, prompting a search for alternatives.

Bladder cancer symptoms often go unnoticed until it's too late. Learn the warning signs most people ignore and how early ...